Becton, Dickinson and Co. | BDX - Interest Expense On Debt



Becton, Dickinson and Co. reported $152M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Abbott USD 50M 1000K Jun/2025
Agilent USD 28M 1000K Jul/2025
Align Technology 0 0 Sep/2024
Avanos Medical USD 2M 100K Jun/2025
Baxter International USD 81M 19M Mar/2025
Becton, Dickinson and Co. USD 152M 1000K Jun/2025
Bio-Rad Laboratories USD 12.4M 400K Jun/2025
Boston Scientific USD 90M 8M Jun/2025
Cooper Companies USD 25.4M 1.2M Jul/2025
Danaher USD 71M 1000K Jun/2025
Dentsply International USD 24M 1000K Jun/2025
Dexcom USD 4.7M 0 Jun/2025
Edwards Lifesciences 15.5M 1000K Jun/2024
Exact Sciences USD 9.83M 143K Jun/2025
Globus Medical 4K 9K Jun/2025
Hologic USD 28.9M 200K Jun/2025
Insulet USD 9.5M 8.3M Jun/2025
Integra LifeSciences USD 21.04M 2.23M Jun/2025
Intuitive Surgical 74.9M 18.8M Dec/2024
J&J USD 128M 9M Mar/2025
Masimo USD 8.2M 600K Jun/2025
Medtronic USD 176M 2M Jul/2025
Solventum Corp 103M 1000K Jun/2025
Stryker 42M 11M Sep/2024
Tandem Diabetes Care USD 1.9M 43K Jun/2025
Teleflex USD 21.71M 3.16M Jun/2025
Terumo 1.28B 1.14B Jun/2025
Thermo Fisher Scientific USD 404M 101M Jun/2025
Zimmer Biomet Holdings USD 79.3M 17.4M Jun/2025